Research map: Neurological complications induced by checkpoint inhibitors: characterising the clinical spectra

Back to the article

Papers in this map

  1. Tissue-based map of the human proteome · Mathias Uhlén · 2015 · 16361 citations · Cited by this paper
  2. Neurological implications of chimeric antigen receptor-T cell therapy · 2026 · Related
  3. A clinical approach to diagnosis of autoimmune encephalitis · Francesc Graus · 2016 · 4558 citations · Cited by this paper
  4. Tolerating uncertainty to treat functional motor disorder · 2026 · Related
  5. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update · Bryan J. Schneider · 2021 · 2223 citations · Cited by this paper
  6. Amyloid-β-related angiitis presenting as leptomeningitis · 2026 · Related
  7. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · John B.A.G. Haanen · 2022 · 1289 citations · Cited by this paper
  8. Longitudinal Orthostatic Tremor Study (LOTS): a multi-centre, prospective cohort protocol for characterising orthostatic tremor and orthostatic myoclonus · 2026 · Related
  9. Myasthenia gravis · Nils Erik Gilhus · 2019 · 972 citations · Cited by this paper
  10. Head trauma and environment progression of amyotrophic lateral sclerosis: long-term data from the National ALS Registry · 2026 · Related
  11. Myocarditis in the Setting of Cancer Therapeutics · Marc P. Bonaca · 2019 · 462 citations · Cited by this paper
  12. Bilateral thalamic involvement in scrub typhus meningoencephalitis: a case report of an uncommon neuroimaging pattern mimicking Japanese encephalitis · 2026 · Related
  13. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors · Amanda C. Guidon · 2021 · 230 citations · Cited by this paper
  14. Case of Aicardi-Goutières syndrome diagnosed in adulthood on whole-genome sequencing · 2026 · Related
  15. Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis · Urania G. Dafni · 2019 · 229 citations · Cited by this paper
  16. Impact of whole-body vibration training on gait in patients with progressive multiple sclerosis: a pilot randomised study · 2026 · Related
  17. Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases · Ranjan Pathak · 2021 · 210 citations · Cited by this paper
  18. Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial · 2026 · Related
  19. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective · Paul Gougis · 2024 · 150 citations · Cited by this paper
  20. Anticoagulation associated intracerebral haemorrhage trends, treatment and outcomes in a metropolitan cohort: analysed by availability of specific versus non-specific reversal agents · 2026 · Related
  21. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature · Kerry Lynn Reynolds · 2018 · 141 citations · Cited by this paper
  22. Association between immune-related adverse event timing and treatment outcomes · David Hsiehchen · 2022 · 98 citations · Cited by this paper
  23. Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system · Chen Chen · 2022 · 37 citations · Cited by this paper
  24. Adjuvant immunotherapy for melanoma patients: progress and opportunities · Tamara A. Sussman · 2024 · 28 citations · Cited by this paper
  25. Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study · Edwin A. Basak · 2022 · 20 citations · Cited by this paper
  26. Neurological immune-related adverse events with checkpoint inhibitor therapy: challenges for the neurologist · Mark A. Willis · 2025 · 17 citations · Cited by this paper
  27. Immune checkpoint inhibitors: From friend to foe · Prem Rajak · 2025 · 9 citations · Cited by this paper
  28. Untitled · Cited by this paper

Source: OpenAlex (CC0)